Multi‐institutional nomogram predicting benign prostate pathology on magnetic resonance/ultrasound fusion biopsy in men with a prior negative 12‐core systematic biopsy

Prostate multiparametric magnetic resonance imaging (mpMRI) may be recommended for patients with a prior negative systematic biopsy (SB). However, a proportion of these patients will continue to have no prostate cancer (PCa) identified on magnetic resonance/ultrasound fusion biopsy (FB) despite abnormal mpMRI findings.

[1]  D. Moses,et al.  A multiparametric magnetic resonance imaging‐based risk model to determine the risk of significant prostate cancer prior to biopsy , 2017, BJU international.

[2]  M. Roethke,et al.  Combined Clinical Parameters and Multiparametric Magnetic Resonance Imaging for Advanced Risk Modeling of Prostate Cancer-Patient-tailored Risk Stratification Can Reduce Unnecessary Biopsies. , 2017, European urology.

[3]  Baris Turkbey,et al.  Prospective Evaluation of PI‐RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System , 2017, The Journal of urology.

[4]  B. Hadaschik,et al.  The Value of PSA Density in Combination with PI‐RADS™ for the Accuracy of Prostate Cancer Prediction , 2017, The Journal of urology.

[5]  E. Messing,et al.  Impact of Gleason Subtype on Prostate Cancer Detection Using Multiparametric Magnetic Resonance Imaging: Correlation with Final Histopathology , 2017, The Journal of urology.

[6]  S. Rais-Bahrami,et al.  Factors predicting prostate cancer upgrading on magnetic resonance imaging–targeted biopsy in an active surveillance population , 2017, Cancer.

[7]  M. Beer,et al.  Follow-up MR imaging of PI-RADS 3 and PI-RADS 4 prostate lesions. , 2017, Clinical imaging.

[8]  A. Doble,et al.  The influence of prostate‐specific antigen density on positive and negative predictive values of multiparametric magnetic resonance imaging to detect Gleason score 7–10 prostate cancer in a repeat biopsy setting , 2017, BJU international.

[9]  A. Sidana,et al.  Current beliefs and practice patterns among urologists regarding prostate magnetic resonance imaging and magnetic resonance-targeted biopsy. , 2017, Urologic oncology.

[10]  S. Rais-Bahrami,et al.  Higher Prostate Cancer Grade Groups Are Detected in Patients Undergoing Multiparametric MRI-targeted Biopsy Compared With Standard Biopsy , 2017, The American journal of surgical pathology.

[11]  David D. Casalino,et al.  Dramatic increase in the utilization of multiparametric magnetic resonance imaging for detection and management of prostate cancer , 2017, Abdominal Radiology.

[12]  D. Margolis,et al.  Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. , 2016, The Journal of urology.

[13]  P. Choyke,et al.  Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection. , 2016, The Journal of urology.

[14]  P. Choyke,et al.  Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions. , 2016, Journal of the National Cancer Institute.

[15]  P. Asbach,et al.  Prostate cancer detection on transrectal ultrasonography‐guided random biopsy despite negative real‐time magnetic resonance imaging/ultrasonography fusion‐guided targeted biopsy: reasons for targeted biopsy failure , 2016, BJU international.

[16]  H. Thoeny,et al.  Prostate MRI based on PI-RADS version 2: how we review and report , 2016, Cancer Imaging.

[17]  D. Margolis,et al.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2. , 2016, European urology.

[18]  A. Rosenkrantz,et al.  Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies. , 2015, Urology.

[19]  D. Nieboer,et al.  Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis. , 2015, European urology.

[20]  C. Roehrborn,et al.  Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy. , 2015, Urologic oncology.

[21]  Baris Turkbey,et al.  Clinical implications of a multiparametric magnetic resonance imaging based nomogram applied to prostate cancer active surveillance. , 2015, The Journal of urology.

[22]  P. Choyke,et al.  Comparison of magnetic resonance imaging and ultrasound (MRI‐US) fusion‐guided prostate biopsies obtained from axial and sagittal approaches , 2015, BJU international.

[23]  Baris Turkbey,et al.  Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer. , 2015, JAMA.

[24]  H. Haxhimolla,et al.  mp-MRI Prostate Characterised PIRADS 3 Lesions are Associated with a Low Risk of Clinically Significant Prostate Cancer - A Retrospective Review of 92 Biopsied PIRADS 3 Lesions , 2015, Current Urology.

[25]  P. Pinto,et al.  Multiparametric magnetic resonance imaging (MRI) and subsequent MRI/ultrasonography fusion‐guided biopsy increase the detection of anteriorly located prostate cancers , 2014, BJU international.

[26]  Maarten de Rooij,et al.  Cost-effectiveness of magnetic resonance (MR) imaging and MR-guided targeted biopsy versus systematic transrectal ultrasound-guided biopsy in diagnosing prostate cancer: a modelling study from a health care perspective. , 2014, European urology.

[27]  Shyam Natarajan,et al.  Value of targeted prostate biopsy using magnetic resonance-ultrasound fusion in men with prior negative biopsy and elevated prostate-specific antigen. , 2014, European urology.

[28]  P. Choyke,et al.  Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer , 2013, Cancer.

[29]  Baris Turkbey,et al.  Very distal apical prostate tumours: identification on multiparametric MRI at 3 Tesla , 2012, BJU international.

[30]  G. Raj,et al.  How to build and interpret a nomogram for cancer prognosis. , 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[31]  E. Riches.  INTERNATIONAL SOCIETY OF UROLOGY , 1958 .